Get notified when JAGX files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Delisting (new) — Company faces imminent delisting from Nasdaq if it fails to maintain $1.00 bid price for 10 consecutive days by May 18, 2026.
NASDAQ: JAGX Jaguar Health, Inc. 8-K

Jaguar Health granted 3-day extension to avoid Nasdaq delisting, deadline now May 18

Filed May 7, 2026 · Period ending May 6, 2026 · ~1 min read

Key Changes

  • high

    Nasdaq granted extension to May 18, 2026 (from May 15) for Jaguar to maintain $1.00 bid price for 10 consecutive days or face delisting from the exchange.

    Item 3.01 view on EDGAR →
  • high

    Company regained compliance with 500,000 publicly held shares requirement on May 4 after warrant exercises, but this reset the clock on bid price compliance.

    Item 3.01 view on EDGAR →
  • medium

    Jaguar had received two separate non-compliance notices from Nasdaq in early May: one for publicly held shares (now resolved) and one for minimum bid price (still outstanding).

    Item 3.01 view on EDGAR →

1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (FNGR 10-Q) is open in full — no account needed.

Partner

Trade JAGX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify